# Topotecan in Treating Patients With Relapsed Small Cell Lung Cancer

> **NCT00003917** · PHASE3 · COMPLETED · sponsor: **Case Comprehensive Cancer Center** · enrollment: 4 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** topotecan hydrochloride

## Key facts

- **NCT ID:** NCT00003917
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-03
- **Primary completion:** 2001-11
- **Final completion:** 2001-11
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2014-01-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003917, "Topotecan in Treating Patients With Relapsed Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00003917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*